Credit card Yonder Announces Launch of Flights to its Rewards Programme With new Ad "The Useless Companion"
Jun. 10, 2024
The rewards credit card Yonder has today released The Useless Companion - a playful ad that marks the introduction of flights to its rewards programme.
Unlike the flight-based rewards offered by its rivals, Yonder points can be used with any airline, to any destination and at any time, without the need for vouchers or activation codes - limitations that are often expressed as pain-points in public reviews by customers of competitors. The Useless Companion highlights these pain points, disguising them as a discussion about a seemingly tricky relationship in therapy before the reveal.
The script was loosely based on Trustpilot reviews left by the customers of other providers after trying to spend their points on flights, and the ad ends with the offer of a free guided meditation for any viewers who may relate to the same frustration.
Developed by Yonder and produced by Perspective Pictures, the 60 second ad is available to watch on YouTube.
Related News
Yonder Launches Armflex Wrist Support for Shoppers Feeling the Strain
New wrist support launched to give clinically unproven relief from the pain of rewards card rejection at the till
Yonder Delivers new PM a Complimentary Membership as London's Newest Resident
The package included an "in case of emergency, break glass" box for when a reward or two is needed at the end of a stressful day
Wimbledon's Queue Gets its First (Un) Official Sponsor
Credit card startup Yonder gears up tennis fans at dawn as the first "(Un)Official Sponsor of The Queue" on opening day of Wimbledon
Latest News
Oct. 16, 2026
Midnite Serves 1,000 Free Chicken Parmos to Boro Fans This Weekend
Earlier this month, Middlesbrough legends went head-to-head with current first-team players in a Parmo Cooking Challenge
Oct. 16, 2026
Only One in Four UK Adults Recall Live Brand Experiences, but 96% Take Action
Of those who acted, 91% said the experience influenced what they did; product trial was associated with stronger future brand consideration